US Khoo

5.7k total citations · 1 hit paper
131 papers, 3.7k citations indexed

About

US Khoo is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, US Khoo has authored 131 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 30 papers in Oncology and 24 papers in Genetics. Recurrent topics in US Khoo's work include Gestational Trophoblastic Disease Studies (16 papers), Prenatal Screening and Diagnostics (14 papers) and Ovarian cancer diagnosis and treatment (14 papers). US Khoo is often cited by papers focused on Gestational Trophoblastic Disease Studies (16 papers), Prenatal Screening and Diagnostics (14 papers) and Ovarian cancer diagnosis and treatment (14 papers). US Khoo collaborates with scholars based in Hong Kong, China and United Kingdom. US Khoo's co-authors include Any Cheung, Kelvin Y.K. Chan, Hys Ngan, Ellen P.S. Man, Eric W.‐F. Lam, Ana Gomes, Chun Gong, Wei‐Cheng Xue, Pei-Chen Chiu and Vera Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The Journal of Experimental Medicine.

In The Last Decade

US Khoo

124 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

2011 361 citations US Khoo et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by US Khoo

Since Specialization

Citations

This map shows the geographic impact of US Khoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by US Khoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites US Khoo more than expected).

Fields of papers citing papers by US Khoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by US Khoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by US Khoo. The network helps show where US Khoo may publish in the future.

Co-authorship network of co-authors of US Khoo

This figure shows the co-authorship network connecting the top 25 collaborators of US Khoo. A scholar is included among the top collaborators of US Khoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with US Khoo. US Khoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis 2025 ·Clinical and Translational Medicine ·Yu Liu, (unknown), (unknown), Jie Zhong, US Khoo, Yu‐Xiong Su, (unknown)	4
2	301 (PB289): BQ323636.1 modulates the AR-CDK20 axis to confer doxorubicin resistance in breast cancer 2024 ·European Journal of Cancer ·US Khoo, (unknown), (unknown), Ho Tsoi	0
3	Students’ motivation and engagement in interprofessional education: the mediating role of peer relatedness 2024 ·Medical Education Online ·Fraide A. Ganotice, Norman B. Mendoza, (unknown), (unknown), Jetty Chung‐Yung Lee, Enoch Chan, Pauline Luk, (unknown), Qing He, US Khoo, (unknown), (unknown), Amy Yin Man Chow, Ning Wang, George L. Tipoe	4
4	Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer 2023 ·The Journal of Pathology ·Ho Tsoi, (unknown), (unknown), (unknown), (unknown), (unknown), Sum‐Yin Chan, Wing‐Lok Chan, US Khoo	2
5	To IPAS or not to IPAS? Examining the construct validity of the Interprofessional Attitudes Scale in Hong Kong 2021 ·Journal of Interprofessional Care ·Fraide A. Ganotice, Amy Yin Man Chow, (unknown), US Khoo, (unknown), (unknown), (unknown), Ning Wang, George L. Tipoe	6
6	Using Risk Stratification to Optimize Mammography Screening in Chinese Women 2021 ·JNCI Cancer Spectrum ·Kathy Leung, Joseph T. Wu, (unknown), Xiao‐Ou Shu, Wei Zheng, Wanqing Wen, US Khoo, Roger K.C. Ngan, Ava Kwong, GM Leung	2
7	BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer 2018 ·Clinical Cancer Research ·Chun Gong, Ellen P.S. Man, Ho Tsoi, Terence K. Lee, Paul Lee, (unknown), Lai‐San Wong, Mai‐Yee Luk, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Eric W.‐F. Lam, Kwok‐Leung Cheung, US Khoo	19
8	Dual-utility NLS drives RNF169-dependent DNA damage responses 2017 ·Proceedings of the National Academy of Sciences ·Liwei An, Yiyang Jiang, (unknown), Ellen P.S. Man, Jie Chen, US Khoo, Qingguo Gong, Michael S.Y. Huen	53
9	RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment 2016 ·Oncogenesis ·Mesayamas Kongsema, Stefania Zona, (unknown), (unknown), Ellen P.S. Man, (unknown), Akifumi Shibakawa, US Khoo, René H. Medema, Raimundo Freire, Eric W.‐F. Lam	31
10	OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance 2015 ·Oncogene ·(unknown), Mesayamas Kongsema, Stefania Zona, Chun Gong, (unknown), Ana Gomes, Ellen P.S. Man, Pasarat Khongkow, (unknown), US Khoo, René H. Medema, Raimundo Freire, Eric W.‐F. Lam	122
11	FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer 2014 ·Oncogene ·Chun Gong, (unknown), Lara J. Monteiro, Ana Gomes, Rinske Drost, Hazel Davidson‐Smith, Satoru Takeda, US Khoo, Jos Jonkers, Duncan Sproul, Eric W.‐F. Lam	32
12	Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer 2013 ·Current Molecular Medicine ·(unknown), (unknown), (unknown), US Khoo, (unknown)	33
13	SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated with Tamoxifen Resistance and Control of ERα Transcriptional Activity 2012 ·Cancer Research ·(unknown), Chun Gong, (unknown), Nan Yang, Oscar Gee‐Wan Wong, Any Cheung, Janice Tsang, Kelvin Y.K. Chan, US Khoo	28
14	Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity. 2010 ·PubMed ·Kelvin Y.K. Chan, (unknown), (unknown), Vera Chan, Ying Chi Ip, Loretta Yin-Chun Yam, Chung‐Ming Chu, S. T. Lai, (unknown), Tien Yin Wong, (unknown), (unknown), Shea Ping Yip, Pak C. Sham, (unknown), GM Leung, Malik Peiris, US Khoo	19
15	Functional role of ICAM-3 polymorphism in genetic susceptibility to SARS infection. 2009 ·PubMed ·US Khoo, Kelvin Y.K. Chan, (unknown), Vera Chan, Ying Chi Ip, Loretta Yin-Chun Yam, Chung‐Ming Chu, S. T. Lai, (unknown), Tien Yin Wong, (unknown), (unknown), Shea Ping Yip, Pak C. Sham, GM Leung, (unknown), Malik Peiris	2
16	A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung 2007 ·The Journal of Experimental Medicine ·Yongxiong Chen, Vera Chan, Bo‐Jian Zheng, Kelvin Y.K. Chan, Xiao‐Ning Xu, (unknown), (unknown), US Khoo, (unknown)	37
17	Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility 2006 ·Carcinogenesis ·(unknown), Kelvin Y.K. Chan, Hys Ngan, US Khoo, Pei-Chen Chiu, Queeny K.Y. Chan, Weizhi Xue, Any Cheung	39
18	Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease: correlation with mdm2, proliferation index, and clinicopathologic parameters 1999 ·International Journal of Gynecological Cancer ·Any Cheung, Shen, US Khoo, (unknown), (unknown), (unknown), Hys Ngan	29
19	Fine Needle Aspiration Cytology of Myxopapillary Ependymoma 1998 ·Acta Cytologica ·(unknown), US Khoo, Philip P.C. Ip, Robert J. Collins	9
20	Pseudomyxoma peritonei — a heterogenous disease 1998 ·International Journal of Gynecology & Obstetrics ·(unknown), T.Y. Ng, US Khoo, Weizhi Xue, Any Cheung	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact